Phd in MOLECULAR MEDICINE

Research: Matched germline and tumor profiling in MBC patients

NAME: Giulia Conti
DATE AND PLACE OF BIRTH: 18/10/1995, Florence
PHONE NUMBER: +39 0649918266
E-MAIL ADDRESS: giulia.conti@uniroma1.it
WORK ADDRESS: PhD fellow at Department of Molecular Medicine, Sapienza University of Rome.

PREVIOUS RESEARCH EXPERIENCE:
July 2023 – October 2023: Research fellow at the Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, Scotland (UK).
October 2020 - October 2021: Studentship laboratory training at Department of Molecular Medicine, Sapienza University of Rome. Research focus: “Multigene Panel Analysis in Male Breast Cancer Genetic Susceptibility”.
October 2018 - June 2019: Studentship laboratory training at Department of Biology, University of Florence.

CAREER:
February 2023: Course in “Introduzione all’analisi dei dati biomedici con R-Studio”, Sapienza University of Rome.
October 2021: Second level Degree in “Genomics, Industrial and Environmental Biotechnology”, Sapienza University of Rome.
June 2019: First level Degree in “Biotechnology”, University of Florence.


SKILLS:
- DNA and RNA extraction and purification from blood and paraffin-embedded samples.
- Polymerase Chain Reaction (PCR) and gel electrophoresis.
- Real-Time PCR (TaqMan and SYBR green).
- Sanger sequencing.
- High-throughput sequencing (Pyrosequencing/Illumina platform/Ion Torrent).
- Bioinformatics and biostatistics skills: in silico analysis, sequencing analysis software, use of online databases; knowledge of R software.

Congress participation:

1- Silvestri V, Valentini V, Bucalo A, Conti G, Karimi M, Porzio V, Ottini L. The multi-omics based immune landscape of BRCA1/2-positive and -negative male breast tumors. Parma (Italy), 22-23 Sept, 2023.

2- Silvestri V, Valentini V, Bucalo A, Conti G, Karimi M, Porzio V, Ottini L. The multi-omics based immune landscape of BRCA1/2-positive and -negative male breast tumors. BRCA 2023: Moving into the Mainstream, Montreal 2-5 May, 2023

3- Silvestri V, Valentini V, Bucalo A, Conti G, Karimi M, Porzio V, Ottini L. The multi-omics based immune landscape of BRCA1/2-positive and -negative male breast tumors. . EACR-AACR-SIC- Immune Responses & DNA Repair, Florence (Italy), 15-17 March, 2023.

4- Valentini V, Silvestri V, Bucalo A, Conti G, Karimi M, Zanna I, Cortesi L, Calistri D, Tibiletti MG, D’amati G, Coppa A, Giannini G, Palli D, Ottini L. Possible prognostic and predictive value of tumor mutational burden in male breast tumors characterized for germline mutations in DNA repair genes. 62nd Annual Meeting of the Italian Cancer Society- The exciting path from preclinical research to clinical application. Venice November 16-18, 2022.

5- Silvestri V, Valentini V, Bucalo A, Conti G, Karimi M, Zanna I, Cortesi L, Calistri D, Tibiletti MG, D’amati G, Coppa A, Giannini G, Palli D, Ottini L. Profiling immunophenotypes in male and female BRCA-associated breast cancers. 62nd Annual Meeting of the Italian Cancer Society- The exciting path from preclinical research to clinical application. Venice November 16-18, 2022.

6- Bucalo A, Conti G, Valentini V, Bonanni B, Calistri D, Cortesi L, Giannini G, Manoukian S, Manzella L, Montagna M, Peterlongo P, Radice P, Russo A, Tibiletti MG, Turchetti D, Varesco L, Viel A, Zanna I, Silvestri V, Ottini L. Genetic risk assessment using multi-gene panel testing in male breast cancer: toward gender-specific precision prevention. 62nd Annual Meeting of thE Italian Cancer Society- The exciting path from preclinical research to clinical application. Venice November 16-18, 2022.

7- Conti G, Bucalo A, Valentini V, Zanna I, Tibiletti MG, Russo A, Varesco L, Coppa A, Calistri D, Cortesi L, Viel A, Bonanni B, Manoukian S, Montagna M, Radice P, Palli D, Peterlongo P, Giannini G, Silvestri V, Ottini L. Improving gender-specific breast cancer precision prevention: genetic risk assessment using multi-gene panel testing in male breast cancer. Società Italiana di Patologia e Medicina Traslazionale (SIPMeT), 2022, Ancona, (Italy), 22-24 Sept, 2022.

8- Valentini V, Silvestri V, Bucalo A, Conti G, Karimi M, D’Amati G, Coppa A, Giannini G, Ottini L. Molecular tumor profiling in male breast cancer by targeted gene panel sequencing. 7th ACC ANNUAL MEETING NEW TECHNOLOGIES AND STRATEGIES TO FIGHT CANCER Rome - September 21-22-23, 2022.

9- Bucalo A, Silvestri V, Conti G, Valentini V, Karimi M, Zanna I, Tommasi S, Tibiletti MG, Russo A, Varesco L, Coppa A, Calistri D, Cortesi L, Viel A, Bonanni B, Manoukian S, Montagna M, Radice P, Palli D, Peterlongo P, Ottini L. Investigating genetic susceptibility to male breast cancer by multigene panel testing: an Italian population-based case-control study. Società Italiana di Genetica Umana (SIGU) 2022, Trieste, (Italy), 7-10 Sept, 2022.

10- Valentini V, Silvestri V, Karimi M, Bucalo A, Conti G, Zanna I, Cortesi L, Calistri D, D’Amati G, Ottini L. Tumor Mutational Burden in Male Breast Cancers characterized for germline mutations in DNA repair genes. EACR 2022 Congress - Innovative Cancer Science: Translating Biology to Medicine. Seville (Spain), 20-23 June 2022.

11- Bucalo A, Silvestri V, Conti G, Valentini V, Karimi M, Zanna I, Tommasi S, Tibiletti MG, Russo A, Varesco L, Coppa A, Calistri D, Cortesi L, Viel A, Bonanni B, Manoukian S, Montagna M, Radice P, Palli D, Peterlongo P, Ottini L. Iinvestigating genetic susceptibility to male breast cancer by multigene panel testing: an Italian population-based case-control study. European Society of Human Genetics (ESHG) 2022, Vienna (Austrian), 11-16 June, 2022.